Turning Point Therapeutics Investors
Turning Point Therapeutics is a private equity firm based in San Diego, California, founded in 2013 The firm specializes in developing targeted therapies for cancer treatment, leveraging innovative approaches to address unmet medical needs With a significant investment scale of $166,500,000, Turning Point Therapeutics is committed to advancing its pipeline of therapeutics through rigorous research and development efforts The firm aims to create transformative therapies that improve patient outcomes and enhance the quality of life for those affected by cancer
%20.jpg)
Founded Date:
2013
Last Funding Type:
Post-IPO Equity
Headquarters:
USA
Investors Number:
11
Technology:
Anti-infective Drugs
Employee Number:
51-100
Industry:
FemTech
Estimated Revenue:
$50M to $100M
Funding Status:
IPO
Investor Type:
Private Equity Firms
Total Funding:
$720.7M